The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Postmenopausal Estrogen Use, Cigarette Smoking, and Cardiovascular Morbidity in Women over 50: The Framingham Study
Abstract
We studied the effect of estrogen use on morbidity from cardiovascular disease in 1234 postmenopausal women, aged 50 to 83 years, participating in the Framingham Heart Study's 12th biennial examination (index examination). The medication history recorded at biennial examinations 8 through 12 was used to classify the degree of estrogen exposure before eight years of observation for cardiovascular morbidity and mortality. Despite a favorable cardiovascular risk profile and control for the major known risk factors for heart disease, women reporting postmenopausal estrogen use at one or more examinations had over a 50 per cent elevated risk of cardiovascular morbidity (P less than 0.01) and more than a twofold risk for cerebrovascular disease (P less than 0.01) after the index examination. Increased rates for myocardial infarction (P less than 0.05) were observed particularly among the estrogen users who smoked cigarettes. Conversely, among nonsmokers estrogen use was associated only with an increased incidence of stroke (P less than 0.05). No benefits from estrogen use were observed in the study group; in particular, mortality from all causes and from cardiovascular disease did not differ for estrogen users and nonusers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Abell, L. L., Levy, B. B., Brodie, B. B., & Kendall, F. E. (1952) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50907-3 · Cited by 3,086
Estimation of the probability of an event as a function of several independent variables
WALKER, S. H., & DUNCAN, D. B. (1967) · Biometrika · doi:10.1093/biomet/54.1-2.167 · Cited by 1,682
Incidence and Prognosis of Unrecognized Myocardial Infarction: An Update on the Framingham Study
Kannel, W. B., & Abbott, R. D. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411013111802 · Cited by 1,018
Menopause and Coronary Heart Disease: The Framingham Study
GORDON, T., KANNEL, W. B., HJORTLAND, M. C., & McNAMARA, P. M. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-89-2-157 · Cited by 888
Oral Contraceptives and Cardiovascular Disease
Stadel, B. V. (1981) · New England Journal of Medicine · doi:10.1056/nejm198109103051104 · Cited by 494
MENOPAUSAL OESTROGEN THERAPY AND PROTECTION FROM DEATH FROM ISCHAEMIC HEART DISEASE
Ross, R., Mack, T., Paganini-Hill, A., Arthur, M., & Henderson, B. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92138-3 · Cited by 356
The Effect of Estrogen Dose on Postmenopausal Bone Loss
Horsman, A., Jones, M., Francis, R., & Nordin, C. (1983) · New England Journal of Medicine · doi:10.1056/nejm198312083092301 · Cited by 214
USE OF ORAL CONTRACEPTIVES, CIGARETTE SMOKING, AND RISK OF SUBARACHNOID HÆMORRHAGE
Petitti, D., & Wingerd, J. (1978) · The Lancet · doi:10.1016/s0140-6736(78)91745-2 · Cited by 195
CARDIOVASCULAR-DISEASE MORTALITY TRENDS AND ORAL-CONTRACEPTIVE USE IN YOUNG WOMEN
Beral, V. (1976) · The Lancet · doi:10.1016/s0140-6736(76)90966-1 · Cited by 172
Myocardial Infarction and Estrogen Therapy in Post-Menopausal Women
Rosenberg, L., Armstrong, B., & Jick, H. (1976) · New England Journal of Medicine · doi:10.1056/nejm197606032942302 · Cited by 168
Use of postmenopausal hormones and risk of myocardial infarction.
Bain, C., Willett, W. C., Hennekens, C. H., ROSNER, B. A., Belanger, C. F., & Speizer, F. E. (1981) · Circulation · doi:10.1161/01.cir.64.1.42 · Cited by 126
Gibbs, J. R. (1960) · The Lancet · doi:10.1016/s0140-6736(60)91793-1 · Cited by 118
CORONARY RISK AND ESTROGEN USE IN POSTMENOPAUSAL WOMEN1
PFEFFER, R. I., Whipple, G. H., Kurosaki, T., & CHAPMAN, J. M. (1978) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112567 · Cited by 114
Heart Disease Risk Factors and Hormone Use in Postmenopausal Women
Barrett-Connor, E. L., Brown, W. V., Turner, J. E., Austin, M. A., & Criqui, M. H. (1979) · JAMA · doi:10.1001/jama.1979.03290460031015 · Cited by 99
Noncontraceptive Estrogens and Nonfatal Myocardial Infarction
Jick, H. (1978) · JAMA · doi:10.1001/jama.1978.03280410049017 · Cited by 89
CHARACTERISTICS OF MENOPAUSAL WOMEN: A SURVEY OF KING AND PIERCE COUNTIES IN WASHINGTON, 1973–1974
Stadel, B. V., & Weiss, N. S. (1975) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112149 · Cited by 79
Estrogen use, hypertension and stroke in postmenopausal women
PFEFFER, R. I. (1978) · Journal of Chronic Diseases · doi:10.1016/0021-9681(78)90003-6 · Cited by 73
PATTERNS AND DETERMINANTS OF CONJUGATED ESTROGEN USE
Rosenberg, L. A., Shapiro, S., Kaufman, D. W., Slone, D., Miettinen, O. S., & Stolley, P. D. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112731 · Cited by 43
Cited by
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Self-citationHormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
Grady, D., Rubin, S. M., Petitti, D. B., Fox, C. S., Black, D., Ettinger, B., Ernster, V. L., & Cummings, S. R. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-12-1016 · Cited by 2,336
Stampfer, M. J., Colditz, G. A., Willett, W. C., Manson, J. E., Rosner, B., Speizer, F. E., & Hennekens, C. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109123251102 · Cited by 1,997
Riggs, B. L., & Melton, L. J. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606263142605 · Cited by 1,915
Stampfer, M. J., & Colditz, G. A. (1991) · Preventive Medicine · doi:10.1016/0091-7435(91)90006-p · Cited by 1,600
Metadata
- Authors
- Wilson, P. W. F., Garrison, R. J., & Castelli, W. P.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1985-10-24
- Volume
- 313
- Issue
- 17
- Pages
- 1038-1043
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2341031326
- Cited by
- 601
- References
- 18
- FWCI
- 22.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.